CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 53 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,222,000 | -36.2% | 745,000 | -6.3% | 0.01% | -37.5% |
| Q4 2021 | $1,916,000 | -31.2% | 795,000 | +38.3% | 0.01% | -33.3% |
| Q3 2021 | $2,783,000 | -10.5% | 575,000 | +194.8% | 0.01% | -14.3% |
| Q3 2017 | $3,109,000 | +10.6% | 195,034 | -16.1% | 0.01% | -12.5% |
| Q2 2017 | $2,812,000 | -66.8% | 232,383 | -43.1% | 0.02% | -66.0% |
| Q1 2017 | $8,480,000 | – | 408,277 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $28,105,000 | 4.42% |
| Novo Holdings A/S | 4,420,516 | $37,928,000 | 3.01% |
| BVF INC/IL | 1,890,507 | $16,221,000 | 1.42% |
| Orbimed Advisors | 5,967,584 | $51,202,000 | 0.62% |
| COWEN INC. | 588,706 | $5,051,000 | 0.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,000 | $710,000 | 0.34% |
| SPHERA FUNDS MANAGEMENT LTD. | 321,430 | $2,758,000 | 0.32% |
| EcoR1 Capital, LLC | 351,401 | $3,015,000 | 0.27% |
| Rock Springs Capital Management LP | 575,000 | $4,934,000 | 0.18% |
| Hikari Power Ltd | 32,090 | $275,000 | 0.03% |